Dexcom Rival Fights Its Bid To Tweak Glucose Monitor Patent

By Jamie Lennox · February 28, 2024, 7:51 PM GMT

A Korean medical tech company has asked a London court to block Dexcom's bid to tweak its diabetes management patent to avoid losing protections should the court rule that it's invalid....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Compound GLP-1s, Anesthesia Prices And More In Court No Photo Available

Gianna Ferrarin

Law360 Healthcare Authority looks at appellate arguments from compounding pharmacies alleging they were wrongly barred from making the... (more story)

FTC's Probes Of Trans Care Orgs Raise Jurisdiction Concerns No Photo Available

Mark Payne

The Federal Trade Commission's demands for information from transgender care organizations may be exceeding the agency's authority to ... (more story)

Pacemaker Co. Seeks Clarity on Qui Tam Publicity Test No Photo Available

Dan McKay

A medical device company is asking the U.S. Supreme Court to clarify the False Claims Act's public disclosure bar. To succeed, the com... (more story)